Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease.
about
Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis.Chitinase-3-like Protein 1: A Progranulin Downstream Molecule and Potential Biomarker for Gaucher Disease.Changes in serum chitinase 3-like 1 levels correlate with changes in liver fibrosis measured by two established quantitative methods in chronic hepatitis B patients following antiviral therapy.Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT.
P2860
Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum YKL-40 as a marker of li ...... alcoholic fatty liver disease.
@en
Serum YKL-40 as a marker of li ...... alcoholic fatty liver disease.
@nl
type
label
Serum YKL-40 as a marker of li ...... alcoholic fatty liver disease.
@en
Serum YKL-40 as a marker of li ...... alcoholic fatty liver disease.
@nl
prefLabel
Serum YKL-40 as a marker of li ...... alcoholic fatty liver disease.
@en
Serum YKL-40 as a marker of li ...... alcoholic fatty liver disease.
@nl
P2093
P2860
P356
P1433
P1476
Serum YKL-40 as a marker of li ...... alcoholic fatty liver disease.
@en
P2093
Erina Kumagai
Hideyuki Hyogo
Hirotaka Shoji
Kazuaki Chayama
Kiyoaki Ito
Masaaki Korenaga
Masanori Atsukawa
Masashi Mizokami
Masashi Yoneda
Masaya Sugiyama
P2860
P2888
P356
10.1038/SREP35282
P407
P577
2016-10-14T00:00:00Z